Correlation Between Mineralys Therapeutics, and BeiGene
Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and BeiGene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and BeiGene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mineralys Therapeutics, Common and BeiGene, you can compare the effects of market volatilities on Mineralys Therapeutics, and BeiGene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of BeiGene. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and BeiGene.
Diversification Opportunities for Mineralys Therapeutics, and BeiGene
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Mineralys and BeiGene is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and BeiGene in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BeiGene and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with BeiGene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BeiGene has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and BeiGene go up and down completely randomly.
Pair Corralation between Mineralys Therapeutics, and BeiGene
Given the investment horizon of 90 days Mineralys Therapeutics, Common is expected to generate 2.66 times more return on investment than BeiGene. However, Mineralys Therapeutics, is 2.66 times more volatile than BeiGene. It trades about -0.05 of its potential returns per unit of risk. BeiGene is currently generating about -0.29 per unit of risk. If you would invest 1,389 in Mineralys Therapeutics, Common on August 27, 2024 and sell it today you would lose (119.00) from holding Mineralys Therapeutics, Common or give up 8.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Mineralys Therapeutics, Common vs. BeiGene
Performance |
| Timeline |
| Mineralys Therapeutics, |
| BeiGene |
Mineralys Therapeutics, and BeiGene Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mineralys Therapeutics, and BeiGene
The main advantage of trading using opposite Mineralys Therapeutics, and BeiGene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, BeiGene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BeiGene will offset losses from the drop in BeiGene's long position.| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. HCW Biologics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals |
| BeiGene vs. Eliem Therapeutics | BeiGene vs. HCW Biologics | BeiGene vs. Scpharmaceuticals | BeiGene vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |